Current and future issues in the manufacturing and development of monoclonal antibodies
- 7 August 2006
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 58 (5-6), 707-722
- https://doi.org/10.1016/j.addr.2006.05.002
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Studying Protein Aggregation by Programmed Flow Field-Flow Fractionation Using Ceramic Hollow FibersAnalytical Chemistry, 2005
- Minimizing the Immunogenicity of Antibodies for Clinical ApplicationTumor Biology, 2005
- Three-Dimensional Electron Microscopy at Molecular ResolutionAnnual Review of Biophysics and Biophysical Chemistry, 2004
- Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular LymphomaJournal of Clinical Oncology, 2003
- The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular CytotoxicityJournal of Biological Chemistry, 2003
- Mastering MacromoleculesScience, 2002
- Characterization of pH-induced transitions of β-lactoglobulin: ultrasonic, densimetric, and spectroscopic studiesJournal of Molecular Biology, 2001
- Overcoming obstacles to monoclonal antibody product development and approvalTrends in Biotechnology, 1997
- Validation of biotechnology products and processesCurrent Opinion in Biotechnology, 1995
- The Use of Peptide Mapping for the Detection of Heterogeneity in Recombinant DNA-derived ProteinsBiologicals, 1993